•Apply clinical disease trajectory and staging literature in ALS to estimate most likely prognosis using available clinical data
•Describe current efficacy and safety of current disease modifying therapies in ALS
•Demonstrate understanding of patient factors specific to ALS in MAiD utilization which impact use
Session date: 
06/23/2025 - 4:00pm to 5:00pm CDT
Location: 
Virtually
United States
See map: Google Maps
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Add to calendar: 
Please login or register to take this course.
Discloser List CME Internal Report